The use of psychotropic drugs in Primary Care: medicalization in the Family Health Strategy in the context of the COVID-19 Pandemic
DOI:
https://doi.org/10.33448/rsd-v12i1.38054Keywords:
Medicalization; Primary care; COVID-19.Abstract
The COVID-19 pandemic was a global challenge for researchers, health managers and governments in the search for public health actions. to slow the rate of increase in contamination, with the aim of preventing the exhaustion of health systems and allowing the appropriate treatment of serious complications. The moment of a pandemic is sensitive regarding the impact of prescription and non-rational and even abusive use of medicines, and its implications extend beyond drugs used directly in the context of COVID-19, these factors are critical for the increase in medicalization. The pandemic crisis has favored the increase in cases of psychic suffering and mental disorders, with a potential impact on the prescriptions of psychotropic drugs. This study aims to analyze the use of medicalization in PHC in the context of the COVID-19 pandemic through an integrative review. Medicalization also delimits behavioral problems, which were not considered medical, but began to be treated pharmacologically, in the context of the COVID-19 pandemic, it was intensified mainly by the consumption of psychotropic drugs as a solution to the daily problems of the population that generate psychic suffering, acceptance of non-pharmacological approaches are infrequent and valued.
References
Alves, A. M., et al. (2021). Medicalização do luto: limites e perspectivas no manejo do sofrimento durante a pandemia. Cadernos de Saúde Pública online. 37(9).
Aquino, E. M. L., et al. (2020). Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciênc. Saúde Coletiva. 25(supl.1), 2423-46.
Barbosa, R., Japiassu et al. (2020). Como a estratégia de saúde da família pode ser considerada ferramenta de apoio no combate ao Covid-19? International Journal of Development Research. 10(05), 36069-74.
Bernieri, J., Hirdes, A., Vendruscolo, C., & Zanata, L. (2021). Fragilidades na atenção à saúde mental: percepções de profissionais da atenção primária à saúde em tempos de COVID-19. Pesquisa, Sociedade e Desenvolvimento, 10(1), 456-81.
BrasilL. (2022). COVID 19 Pinel de controle. Ministério da Saúde.
Castro, C. T., Gama, R. S., Nepomuceno, A. F. S., Figueiredo, M. S., & Castro, B. T. (2020). Atenção primária à saúde frente a pandemia de COVID-19 no Brasil: possiblidades e desafios. AMPLLA. APS 276.
Filardi, A. F. R., Passos, I. C. F., Mendonça, S. A. M., & Oliveira, D. R. (2021). Medicalização da vida nas práticas vinculadas à estratégia saúde da família. Revista Latinoamericana de Psicopatologia Fundamental. 24(2), 421-31
Garcia, A. M. R. V., Amorim, Rodrigues, & Mendonça, L. H. F. (2022). Contrarreforma psiquiátrica brasileira. 10.12957/REP.2022.63525/ Acesso em 19 de setembro de 2022.
Giovanella, L., (2020). O SUS e a Atenção Primária à Saúde na rede de enfrentamento da pandemia. 2020.
Giovanella, L. (2021).Os desafios da vacinação contra Covid-19 na Atenção Primária no SUS.
Li, H., Liu, S. M., Yu, X. H., Tang, S. L., & Tang, C. K. (2020). Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents.
Li, Q., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med.
Madabhavi, I., Sarkar, M., & Kadakol, N. (2020). CoviD-19: A review. Monaldi Arch Chest Dis.
Machado, H. S. V. (2020). Medicalização e medicina de família e comunidade: memórias de um médico de favela.
Meira, K. L., Araújo, F. J., & Rodrigues, R. C. (2021). Impacto da pandemia pelo novo Coronavírus no perfil de consumo de ansiolíticos e antidepressivos na Atenção Básica do Distrito Federal, Brasil. Infarma, Ciências Farmacêuticas,.33 (4) 363-69.
Molina, J. D., & Rubio, G. L. M. F. (2020). Riesgo de la medicalización de las respuestas emocionales tras la cuarentena por la COVID-19, crónica de una crisis evitable. Rev Hum Med.Epub.
Oliveira, G. S., Monteiro, L. S., Carvallho, M. F. A. A., & Freire, A. K. S. (2020). Saúde Mental no avanço da Pandemia de COVID-19: Concepções de trabalhadores da Atenção Primária à Saúde. Pesquisa, Sociedade e Desenvolvimento. 9(1) , 10.
OPAS. (2022). Investment in primary health care urgently needed to ensure COVID-19 recovery in the Americas.
OUR. (2022). World In Data. Coronavirus data explorer.
WHO. (2020). Coronavirus disease 2019 Situation Report 51 11th March 2020. World Health Organization.
WHO. (2022). Coronavirus (COVID-19) Dashboard. World Health Organization.
Xu, X., hen, P., Yng, J., Feng, J., ou H, Li, X., Zhong, W., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Luisa Andrade de Lima
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
